<unk> (Shingrix) is a vaccine that is FDA approved for the prevention of herpes<unk>  (shingles) in adults aged 50 years and older.   Common adverse reactions include pain (78.0%), redness (38.1%), swelling (25.9%), myalgia (44.7%), fatigue (44.5%), headache (37.7%), shivering (26.8%), fever (20.5%), and gastrointestinal symptoms (17.3%).
Zoster vaccine, adjuvanted 
Hepatitis B Vaccine, adjuvanted 
Subunit HIV vaccine
Malaria vaccine
HIV vaccine
PCV regimen
Ebola vaccines
Post-exposure prophylaxis